Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IABC (International Antibody Biotech) is a biotechnology company specializing in the development and production of high-quality antibodies and recombinant proteins for research and diagnostic applications. The company provides a wide range of products including primary and secondary antibodies, ELISA kits, and custom antibody services such as monoclonal and polyclonal antibody production. IABC focuses on supporting the global life sciences community by offering reliable reagents for various experimental techniques like Western Blot, Immunohistochemistry, and Flow Cytometry. Their services extend to protein expression and purification, catering to both academic and industrial clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IABC.